ABOUT US

Syntriqa was launched from a successful collaboration

between Peraison and CG Oncology.

Built on Peraison’s proven track record delivering advanced analytics and data engineering solutions for global organisations including AbbVie, Aspen, and Elekta, Syntriqa applies specialist clinical AI on proven technology foundations.

OUR PEOPLE

Executive Leadership

David Anderson

Chief Executive Officer (CEO)

Tim Watson

Chief Technology Officer (CTO)

Gonçalo Pereira

Chief Operating Officer (COO)

Cameron Johnson

Principal Advisor

Eva Drysdale

Chief Financial Officer (CFO)

Soon To Be Announced

Chief Medical Officer (CMO)

OUR MISSION

Our mission is to help clinical trial teams make better enrolment decisions, faster. Syntriqa combines specialist clinical AI, proven technology foundations, and deep data expertise to improve the speed, consistency, and quality of patient onboarding, enabling sponsors and CROs to operate complex studies with greater precision, auditability, and scale.

Ready to explore more?

Faster enrolment, stronger patient selection, and a more efficient operating model for modern clinical development.